Genuine Impact - Charting Finance, Investing & Tech

Share this post

Embrace Moderna-ty

genuineimpact.substack.com

Embrace Moderna-ty

In this week’s stock analysis we explore two pandemic-gainers that could be back for round 2, and a wire company with eagerly-awaited earnings.

Miguel Benitez
and
Truman
Jul 20, 2022
∙ Paid
2
Share this post

Embrace Moderna-ty

genuineimpact.substack.com
Share

Not all pandemic gainers have crashed and burned - in fact, some stocks are well on their way back up to their previously lofty highs (although we’re still a long way from that yet). This week’s selection includes wire manufacturer Encore Wire ($WIRE), Moderna ($MRNA) of COVID vaccine fame, and cybersecurity leader Crowdstrike ($CRWD).

Encore Wire ($WIR…

Keep reading with a 7-day free trial

Subscribe to

Genuine Impact - Charting Finance, Investing & Tech
to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
Previous
Next
© 2023 Truman
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing